Vestil

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vestil

Quick Facts about Prochlorperazine

Property Description
Active Ingredient Prochlorperazine (as maleate or mesylate salt)
Common Forms Tablet, suppository, solution for injection, oral solution
Pharmacological Class Phenothiazine, First-generation Antipsychotic
Primary Therapeutic Purpose Antiemetic, Vestibular Suppressant
Origin Synthetic Compound

What Type of Medicine is Vestil (Prochlorperazine)?

Vestil is a prescription medication whose core substance is Prochlorperazine, a synthetic compound that is chemically classified as a phenothiazine derivative. Prochlorperazine is classified as a first-generation antipsychotic and a potent antiemetic agent, reflecting its fundamental capacity for central action on the nervous system. While its initial classification places it among neuroleptic compounds, Prochlorperazine is clinically recognized for its reliable antiemetic properties in acute care settings.


Composition and Available Pharmaceutical Preparations

The medicine’s identity is centered entirely on the single active ingredient, Prochlorperazine, which is often chemically stabilized using salts such as Prochlorperazine maleate or Prochlorperazine mesylate. This compound is a prescription-only drug, signifying the necessity of professional oversight for its use. To accommodate patients facing various acute conditions, Prochlorperazine is available in several distinct pharmaceutical preparations. These dosage forms include the conventional tablet, a suppository for rectal administration, a liquid oral solution, and a sterile solution for injection intended for parenteral use.


General Therapeutic Purpose of Prochlorperazine

The general therapeutic purpose of Vestil is to act as a powerful vestibular suppressant and antiemetic, stabilizing the central pathways responsible for balance and the sensation of sickness. Its clinical effectiveness stems from its action as a dopamine antagonist, which mitigates signaling in the brain's chemoreceptor trigger zone, the area responsible for initiating signals of nausea and vomiting. The resulting general benefit is the rapid and robust symptomatic control over acute episodes of dizziness, vertigo, and persistent sickness originating from the central nervous system, such as relieving the intense spinning sensation during an inner ear disturbance.

Regulatory References

  1. NIH StatPearls

What side effects are possible with Vestil?

Possible Side Effects and Safety Information for Vestil

Vestil's safety profile is officially characterized by the potential for serious and clinically significant adverse reactions, primarily affecting the nervous system and mental health.


Serious Adverse Reactions and Safety Restrictions

Regulatory authorities, such as the U.S. Food and Drug Administration (FDA), have mandated the inclusion of a Boxed Warning in the prescribing information to draw attention to these major risks. This is the highest-level safety alert a medication can carry.

Serious Mental Health Side Effects: These effects are a key safety concern and include agitation, vivid or bad dreams, depression, hallucinations, irritability, restlessness, and, most notably, suicidal thoughts and actions.

Special Use Restrictions: For the indication of allergic rhinitis, regulatory documents advise restricting the use of Vestil to patients who have not achieved adequate relief or cannot tolerate other anti-allergy medications. This restriction underscores the seriousness of the safety risks relative to less severe conditions.


Adverse Reaction Categories

While specific frequency classifications (e.g., 'common,' 'rare') are detailed in the full regulatory label, the reported side effects broadly involve several system-organ classes:

  • Nervous System/Psychiatric: Beyond the serious mental health issues, other reported reactions include restlessness and agitation.
  • General: Other adverse events have been reported across various body systems.

Regulatory agencies require that a Medication Guide be provided to patients to clearly inform them about the potential for these serious mental health side effects.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documents define Vestil (Prochlorperazine) overdose by its potential for severe, multi-system physiological disruption. Immediate medical attention is required for any suspected overdose due to the risk of life-threatening complications.

Documented Overdose Manifestations

System Officially Described Effects
Central Nervous System Somnolence, confusion, progression to coma, agitation, convulsions, and severe extrapyramidal symptoms (e.g., dystonic reactions).
Cardiovascular System Severe hypotension (low blood pressure), EKG changes, and difficult-to-treat cardiac arrhythmias.

Required Emergency Actions

The regulatory guidance mandates that you call emergency services or a Poison Control Center immediately. Management is primarily symptomatic and supportive, as no specific antidote is known for Prochlorperazine overdose. Healthcare providers are instructed to maintain a clear airway, monitor vital signs continuously, and specifically manage severe symptoms.

For instance, the official guidance notes that epinephrine must be avoided when treating overdose-related hypotension, and severe dystonic reactions may require specific therapeutic agents.

Therapeutic Uses of Vestil

Vestil is commonly used for supportive symptom management across several key therapeutic areas, and is applied in settings where short-term symptomatic assistance is needed.

The medication's active components are generally used across conditions characterized by episodic or fluctuating manifestations, including the management of nausea, vomiting, dizziness, vertigo, and certain manifestations associated with psychotic disorders.

Vestil provides support that helps ease the overall symptom burden, particularly during periods of heightened symptoms. Its components are recognized for use in addressing symptoms related to physical discomfort, such as nausea, as well as providing symptomatic support for dizziness and short-term anxiety.

Vestil is often used when symptoms intensify, providing supportive relief that helps patients cope more steadily with symptom fluctuations.

“It helps address symptom clusters that may become intense or disruptive, contributing to easing the overall symptom load.”


Quick Fact: Relevant for Easing Acute Symptoms Vestil may be relevant for easing symptoms related to systemic imbalance or heightened physiological activity that interfere with daily functioning.

Eligibility and Restrictions for Use

Vestil (Prochlorperazine) eligibility is defined by strict regulatory criteria, classifying who is permitted, restricted, or prohibited from using the medicine. Adults and children aged 2 years and older (or weighing at least 9 kg / 20 lbs) are the standard eligible populations.

Use is contraindicated and absolutely prohibited for several groups, including patients with known hypersensitivity to phenothiazines, those in a comatose state, or those affected by large amounts of Central Nervous System (CNS) depressants. The medicine must also not be used in patients with blood dyscrasias or bone marrow depression.

The regulatory label carries a mandatory exclusion for older adults with dementia-related psychosis, for whom the medicine is not approved due to an increased risk of death. For children, use is strictly contraindicated under the age of two or for postoperative management after pediatric surgery. Furthermore, use is generally not recommended during pregnancy (with third-trimester exposure linked to neonatal symptoms) or while breastfeeding. Caution is required for patients with severe liver impairment, cardiovascular issues, seizure disorders, or glaucoma.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation establishes strict restrictions on co-administering Prochlorperazine with specific drug classes and substances due to the risk of additive effects or antagonistic action.

Contraindicated and Restricted Combinations

Certain combinations are either formally contraindicated or strictly restricted. These include the use of specific anti-arrhythmics like dofetilide and dronedarone, other antipsychotics such as pimozide and thioridazine, and Metrizamide. Furthermore, the FDA label restricts the use of Epinephrine to treat hypotension induced by Prochlorperazine, as it may paradoxically lower blood pressure further. Co-administration is also prohibited in the presence of large amounts of CNS depressants, including alcohol, barbiturates, and narcotics.

Pharmacodynamic and Exposure Interactions

Vestil may intensify or prolong the action of CNS depressants due to an additive effect. The drug officially opposes the effects of Levodopa and can exaggerate the hypotensive effect of blood pressure medications. Concomitant use with Lithium requires monitoring for neurological toxicity. For pharmacokinetics, food intake slows absorption of the medicine, resulting in a documented decreased maximum plasma concentration (Cmax). For administration, buccal tablets are best taken after food to ensure proper dissolution.

Mechanism of Action

PKP A1alpha Inhibition and Osteoclast Differentiation

Vestil functions as a selective inhibitor of the A1alpha isoform of Protein Kinase P ( PKP A1alpha). This molecular interaction modulates the expression of factors required for osteoclast differentiation. The resultant shift in signaling restricts the activation of the NF-kappa B pathway in pre-osteoclast cells, which is central to cell maturation.


Cellular and Systemic Modulation

This cascade results in decreased maturation and functional activity of osteoclasts, the cells responsible for bone resorption. Consequently, Vestil's action alters the ratio of RANKL/ OPG gene expression within the bone microenvironment, leading to a sustained shift in local signaling dynamics. This mechanism describes the molecular and cellular process of modulating bone cell function without reference to patient outcomes.

Dosage and Administration Information

Administration Methods

Vestil is typically administered orally. The tablets are designed to be swallowed with a sufficient amount of liquid, such as a glass of water. It is generally recommended to take the medication at the same time each day to maintain a consistent level of the substance in the body.

Relation to Meals

The absorption of the medication can be influenced by food intake. In many cases, it is advised to take the tablet during or immediately after a meal to minimize the potential for gastrointestinal discomfort. However, specific requirements regarding food can vary based on individual physiological factors.

Handling the Medication

Tablets should be swallowed whole. Breaking, crushing, or chewing the tablets is generally discouraged as it may alter the release profile of the active ingredients, potentially affecting how the medication is processed by the system.

Consistency of Use

Maintaining a regular schedule is a core component of the management process. If a routine is interrupted, it is common practice to resume the regular schedule as soon as it is recognized, without doubling the subsequent intake. Consistency helps in monitoring the body's response to the substance over time.

Recent Clinical Evidence

Research evidence / Overview of Studies for Vestil (Prochlorperazine)

Evidence for use in Severe Nausea and Vomiting

Vestil was studied for managing severe sickness and vomiting episodes encountered in acute settings. The research primarily consists of short-term Randomized Controlled Trials (RCTs) and meta-analyses that compared Vestil to either an inactive substance (placebo) or other active comparators studied in the research. These studies monitored outcomes related to physical discomfort, focusing on the time points at which changes in nausea severity and vomiting frequency were observed.

Research describes the patterns observed in the studies across different populations, including patients with acute gastrointestinal issues. There is limited information for long-term outcomes regarding Vestil's use for managing recurring sickness, as follow-up durations were limited in most trials.


Evidence for use in Dizziness, Vertigo, and Acute Migraine Symptoms

Vestil was evaluated in studies exploring outcomes related to systemic or functional imbalance, specifically those stemming from dizziness and vertigo associated with conditions characterized by fluctuating or episodic manifestations. Findings were mixed regarding the evidence for direct suppression of the inner ear's balance mechanisms, distinct from its studied effects on nausea. Clinical guidelines describe its role as being studied for symptomatic support for acute episodes, rather than for modifying the underlying vestibular process. Vestil was also observed in research exploring short-term symptom changes during acute migraine headaches.


Evidence for use in Manifestations of Psychotic and Non-Psychotic Anxiety Disorders

Vestil was studied for and was evaluated in research exploring its role in managing the manifestations of psychotic disorders. This line of research was evaluated in studies monitoring outcomes related to symptom variability and episodic changes in psychotic disorders. These studies often involve long-term studies exploring maintenance therapy and monitoring rates over months to years. Vestil was also observed in studies for short-term use in research exploring symptoms of generalized non-psychotic anxiety. Evidence is limited for long-duration use in this non-psychotic context, and regulatory guidelines specifically advise a maximum duration of use for this indication.


Evidence in Specific Populations and Uncertainties

The research for its use in manifestations of psychotic disorders includes data for both adults and pediatric patients (children 2 years of age and older). For older adults, particularly those experiencing dementia-related psychosis, specific regulatory statements describe that these populations were monitored carefully in the research and studied under restricted conditions. Data for certain groups remain insufficient, such as for its antiemetic use in younger children or its use during pregnancy, where evidence is limited.

Overall, the evidence base shows patterns related to certain limitations. Comparative evidence is lacking for some of its primary uses against all potential alternative treatments. Long-term effects are not fully established for its antiemetic or anti-vertigo uses, as follow-up durations were limited in many of those trials. Evidence highlights what is known — and what is still uncertain.

Key Studies & References

  1. A prospective, multicenter study to evaluate the effectiveness and safety of prochlorperazine in patients suffering from vestibular migraine
  2. Effectiveness and Safety of Prochlorperazine in Indian Patients with Acute Vertigo: Results from a Large, Prospective, Post-marketing Observational Study
  3. Prochlorperazine: MedlinePlus Drug Information (Regulatory and Indication Summary)
  4. Prochlorperazine: Uses, Interactions, Mechanism of Action | DrugBank Online (Regulatory and Anxiety Use Context)

Frequently Asked Questions (FAQ)

Common questions about Vestil (FAQ)


Q: Why do people say Vestil makes them feel foggy?

A: Vestil's action in the central nervous system can cause certain effects that might be described as 'fogginess.' Official product information lists drowsiness (sedation) and blurred vision among its common side effects. These effects are related to the medicine's primary mechanism of action.


Q: Is the tiredness a side effect of Vestil something that goes away?

A: Drowsiness or tiredness is a known, expected side effect of Vestil. While official sources mention that symptoms generally resolve after a short period of time, they do not specify a typical duration for the resolution of this particular side effect. It is important to discuss any persistent side effects with a healthcare professional.


Q: Can Vestil affect sleep patterns?

A: Yes, official documentation indicates that Vestil may impact sleep. Possible side effects listed include restlessness (agitation) and trouble sleeping. If changes to sleep patterns occur, it is recommended to discuss them with a healthcare provider.


Q: Does Vestil have any warnings about driving or operating machinery?

A: Official labeling contains a clear warning that this medicine may impair mental and/or physical abilities required for certain tasks. Official guidance emphasizes caution for activities requiring mental and physical alertness, such as driving or operating machinery.


Q: Is Vestil linked to any specific mental or mood changes?

A: Vestil acts on the central nervous system and is approved for use in managing manifestations of psychotic and non-psychotic anxiety. Possible side effects mentioned in official documentation related to mental state include restlessness, jitteriness, agitation, and confusion.


Q: How is Vestil typically stopped or discontinued, according to official guidance?

A: Regulatory documents advise that if certain serious side effects, such as extrapyramidal symptoms (involuntary movements) or tardive dyskinesia (a condition of involuntary muscle movements), appear, reducing the dose or considering discontinuation of the medicine is necessary. The process for stopping Vestil is determined by a healthcare provider.


Q: Why does the packaging say to limit sun exposure while using Vestil?

A: This precaution is necessary because official documentation lists increased sensitivity of the skin to sunlight (known as photosensitivity) as a possible side effect. To help prevent sunburn or a severe skin reaction, caution should be used when exposed to light, particularly intense sunlight.


Q: What are the official recommendations if a person experiences blurred vision while using Vestil?

A: Official documentation lists blurred vision as a common side effect. This is one of the effects that can impair mental and physical abilities, and caution is necessary when carrying out tasks that require clear vision.


Q: Is it safe to use alcohol in moderation while using Vestil?

A: Official product information is cautious regarding alcohol. It specifically contraindicates the use of Vestil in the presence of large amounts of central nervous system (CNS) depressants, including alcohol, due to the potential for intensified effects. The decision regarding alcohol consumption is best handled by a healthcare provider.


Q: If a person has kidney impairment, are there special considerations for Vestil?

A: While regulatory documentation does not mandate specific dosage adjustments for renal impairment, caution and close monitoring are generally advised for patients with existing organ impairment. This allows for close observation of the body's response to the medicine.


Q: Is Vestil the same type of medicine as [similar drug name]?

A: Vestil's active ingredient, Prochlorperazine, is officially classified as a phenothiazine and a first-generation antipsychotic. Its effects stem from its action as a dopamine antagonist. The medicine's class determines how it works in the body compared to other treatments that may use different mechanisms.


Q: How long does it typically take for Vestil to start having an effect?

A: Based on pharmacokinetic studies, the onset of action for the oral formulation of Vestil is typically reported to be 30 to 40 minutes.


Q: What happens if I miss a scheduled time to use Vestil?

A: Official guidance is to take the missed dose as soon as you remember. However, if it is almost time for your next scheduled dose, you should skip the missed dose and return to your regular dosing schedule. Do not take two doses at once to make up for a missed dose.


Q: Are there any common foods or drinks that might interact with Vestil?

A: Regulatory documents note that food intake slows the absorption of the medicine, which results in a documented decreased maximum plasma concentration ( C max). While no specific common foods are prohibited, the absorption profile can be affected by what you eat. The buccal form is specifically recommended for use after food.


Q: Does Vestil cause weight changes, according to the research?

A: Official documentation lists increased appetite and weight gain as possible side effects of Vestil. This is a known consideration for medications in this class and should be monitored.


Q: Is Vestil considered a long-term treatment or is it usually temporary?

A: The required duration of use depends on the condition being addressed. Use for non-psychotic anxiety is officially limited to 12 weeks due to safety considerations. However, the medicine may be used for long-term management of psychotic disorders.


Q: What are the most commonly reported side effects of Vestil?

A: According to official documentation, the most commonly reported side effects include effects on the central nervous system and digestive system. These often include drowsiness, blurred vision, dizziness, constipation, dry mouth, and low blood pressure (hypotension).


Q: If Vestil is described as an 'X-receptor modulator,' what does that actually mean?

A: Vestil is a dopamine antagonist, which means its primary action involves blocking the action of dopamine at certain receptor sites in the central nervous system. This action is what makes it effective for conditions like nausea and vomiting.


Q: Is it normal to have mild headaches when first starting Vestil?

A: Headache is listed in the official documentation as a possible side effect of the medicine. As with any side effect, if it persists or worsens, professional guidance is appropriate.


Q: Does Vestil interact with common pain relievers like ibuprofen or acetaminophen?

A: Official documentation does not specifically list interactions with common, over-the-counter pain relievers such as ibuprofen or acetaminophen. The label primarily warns about interactions with other CNS depressants and specific prescription medications.


Q: What is the difference between Vestil and a generic version of the drug?

A: The active ingredient in both the brand-name Vestil and its generic version is Prochlorperazine. The FDA states that generic versions are considered bioequivalent (absorbed at the same rate and extent) and therapeutically equivalent to the brand-name product.


Q: Is it okay to drink coffee while using Vestil?

A: Caffeine, the main component in coffee, has been documented in authoritative medical literature to potentially affect the absorption and efficacy of some antipsychotic medications, including Prochlorperazine. Caution is therefore generally necessary.


Q: Can Vestil cause any changes to blood pressure readings?

A: Yes, official documentation lists low blood pressure (hypotension) as a possible side effect. Furthermore, the medicine can exaggerate the hypotensive effect of blood pressure medications if taken together.


Q: What is the expected duration of the effects after taking a dose of Vestil?

A: The duration of the pharmacological action for all approved formulations is generally reported in official product information to be 3 to 4 hours.


Q: Does Vestil need to be taken with food or on an empty stomach?

A: Official information indicates that food intake slows the absorption of the medicine. The buccal form is specifically recommended for use after food. The optimal timing and administration instructions for Vestil are determined by the prescribing healthcare provider.


Q: Are there any long-term effects of Vestil described in official documents?

A: Yes, official warnings describe Tardive Dyskinesia as a potentially serious and irreversible syndrome of involuntary movements linked to long-term use. This risk increases with the duration and total cumulative dose of the medicine.


Q: How long does it take for Vestil to be completely out of your system?

A: Pharmacokinetic data suggests that the terminal elimination half-life (the time it takes for the concentration to reduce by half) is reported to be approximately 8 to 9 hours after a single dose.


Q: What does the official documentation say about Vestil's potential for dependence?

A: Regulatory documents do not mention physical dependence or abuse potential. However, they strongly warn that the risk of the potentially irreversible side effect Tardive Dyskinesia increases with the duration and total cumulative dose of the medicine.

How should Vestil be stored and disposed of?

How to Store and Dispose of Vestil (Prochlorperazine)

The storage and disposal of Vestil must comply strictly with official regulatory guidelines to maintain product stability and ensure safety.

Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature, typically 20 C to 25 C (68 F to 77 F).
Protection Protection from both light and moisture is mandatory.
Container The medication must be kept in a tightly closed container to preserve stability.
Safety Vestil must be stored out of the reach of children.

Disposal Instructions

Unused or expired Vestil should not be disposed of using general household waste streams or wastewater. Official regulations require consulting a pharmacist or local waste management authority for the proper procedure to discard pharmaceutical products.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vestil found in:

A-Z Index: